Stevenage, United Kingdom · Founded 2018 · Privately Held (backing)
Operator of cell therapy research and manufacturing platform designed to make bio-processing scalable and affordable for cell and gene therapy. MFX is based in Stevenage, United Kingdom and was founded in 2018. It has raised $19.3 million.
Last price · $/share
—
Implied valuation
—
Total raised
$19.3M
Last round
—
Team — not yet on record
No current team members for MFX are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of MFX with a free account
·The complete investor list: 13 names
·Watch MFX: the Monday email on marks, rounds and moves
